Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-18 · accession 0001735276-25-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-19 | 2025-08-18 | ALNY | BONNEY MICHAEL W | Dir | S - Sale+OE | $450.00 | -11.2K | 16.8K | -40% | -$5.06M |
| D | 2025-08-19 | 2025-08-18 | ALNY | BONNEY MICHAEL W | Dir | M - OptEx | $70.20 | +11.2K | 28.1K | +67% | +$789.8K |
| D | 2025-08-19 | 2025-08-18 | ALNY | BONNEY MICHAEL W | Dir | M - OptEx | $0.00 | -11.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-18 | S | D | 11,250 | $450.00 | 16,804 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-18 | M | A | 11,250 | $70.20 | 28,054 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-08-18 | M | D | 11,250 | $0.00 | 0 | D | $70.20 · 2017-06-03 to 2026-06-03 | 11,250 Common Stock | (F3) The stock option was fully vested as of June 3, 2017. |